Related Experiment Video
Updated: Apr 30, 2026

06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
16.3K
Androgen deficiency and type 2 diabetes mellitus
Fraser W Gibb1, Mark W J Strachan1
1Edinburgh Centre for Endocrinology and Diabetes, UK.
Clinical Biochemistry
|April 29, 2014
Summary
Type 2 diabetes (T2DM) is linked to male hypogonadism, or low testosterone. This review explores the causes, diagnosis, and treatment of this condition in aging men with T2DM.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Men's Health
Background:
- Rising incidence of Type 2 Diabetes Mellitus (T2DM) globally, linked to obesity and aging.
- Association between T2DM, obesity, and aging with increased risk of male hypogonadism (low testosterone).
- Increased testosterone replacement therapy prescriptions in the last decade.
Purpose of the Study:
- To review the pathogenesis, diagnosis, clinical consequences, and management of male hypogonadism in relation to T2DM.
- To explore the complexities in diagnosing androgen deficiency states.
- To examine the established benefits of androgen replacement in younger men versus the less developed evidence in older men.
Main Methods:
- Literature review focusing on male hypogonadism and T2DM.
- Analysis of epidemiological evidence on testosterone deficiency.
- Examination of current therapeutic approaches and their limitations.
Main Results:
- Testosterone deficiency is common in men with T2DM (prevalence of 33% in one cohort).
- Pathogenic mechanisms for diabetes-related hypogonadism are unclear, with multiple theories.
- Limited evidence supports a protective effect of testosterone replacement on cardiovascular disease and mortality.
Conclusions:
- Male hypogonadism is a significant concern in the context of T2DM.
- Diagnosis requires careful consideration of biochemical and clinical factors.
- Further research is needed on the benefits and safety of testosterone replacement in older men, particularly for non-sexual symptoms.
Related Concept Videos
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45

